Telemedicine: A Temporary Fix or a Lasting Solution?
Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.June 21 | 4.00 PM SGT
Telemedicine: A Temporary Fix or a Lasting Solution?
Telemedicine solutions have seen a rise in adoption and normalisation since the COVID-19 pandemic. Global funding for Telemedicine ventures across the world grew by 36%, with the United States contributing the most and APAC following close. The whole Telemedicine ecosystem seems to be flourishing, yet some believe this to be a knee-jerk reaction. Will Telemedicine be a permanent norm in healthcare? Join us as we track its development and challenges in future transformation in a conversation with leading industry experts.June 21 | 4.00 PM SGT
What you will get:
- Additional insights from Galen Growth’s Telemedicine report;
- A better understanding of the telemedicine trajectory;
- Real-world experience and cases.
Speakers
Dr. Yong Chern Chet Expert Mentor, Innovators Commercialisation Program
Serene Cai Co-Founder, Speedoc
Moderators
Miguel Rivera Head of Business Model Transformation, Novartis APMA
Helene Champoux COO, Galen Growth